The U.S. National Institutes of Health (NIH) has finally launched its Long COVID trials to explore potential treatment options after considerable delays sparked intense criticism of the agency.
Long COVID occurs when infected individuals recover from COVID-19 but continue to experience symptoms like headaches, sleep issues, coughing, cognitive impairment, and fatigue for three or more months. One in 13 Americans are estimated to have symptoms of Long COVID. The NIH will now explore treatment options for the condition.
